Profound Medical (TSX:PRN) FCF Yield % : -11.77 (As of May. 26, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Profound Medical FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Profound Medical's Trailing 12-Month Free Cash Flow is C$-28.99 Mil, and Market Cap is C$246.24 Mil. Therefore, Profound Medical's FCF Yield % for today is -11.77%.

The historical rank and industry rank for Profound Medical's FCF Yield % or its related term are showing as below:

TSX:PRN' s FCF Yield % Range Over the Past 10 Years
Min: -34.38 Med: -12.55 Max: -3.91
Current: -11.77

During the past 10 years, the highest FCF Yield % of Profound Medical was -3.91%. The lowest was -34.38%. And the median was -12.55%.

TSX:PRN's FCF Yield % is ranked worse than
68.05% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: -2.815 vs TSX:PRN: -11.77

Profound Medical's FCF Margin % for the quarter that ended in Mar. 2024 was -266.96%.

Profound Medical FCF Yield % Historical Data

The historical data trend for Profound Medical's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Profound Medical FCF Yield % Chart

Profound Medical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-11.48

-5.06

-9.92

-11.59

-12.61

Profound Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-12.05	-7.54	-8.07	-15.87	-9.89

Competitive Comparison of Profound Medical's FCF Yield %

For the Medical Devices subindustry, Profound Medical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Profound Medical's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Profound Medical's FCF Yield % falls into.

Profound Medical FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Profound Medical's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-29.914	/	237.21366
	=	-12.61%

Profound Medical's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-6.901	*	4	/	278.978038
	=	-9.89%

Profound Medical FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Profound Medical FCF Yield % Related Terms

Thank you for viewing the detailed overview of Profound Medical's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Profound Medical (TSX:PRN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Profound Medical Corp (TSX:PRN) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

PROF:USA

Address

2400 Skymark Avenue, Unit 6, Mississauga, ON, CAN, L4W 5K5

Website

https://www.profoundmedical.com

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Executives

Abbey Klair Goodman

Senior Officer